Ascendis Pharma A (ASND) Shares Outstanding (Diluted Average) (2014 - 2026)

Ascendis Pharma A has disclosed Shares Outstanding (Diluted Average) across 13 years of filings, most recently posting $11.4 million for Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $11.4 million, up 586.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.4 million (up 586.82% YoY), and the FY2025 annual result was $4.4 million, down 37.28% from the prior year.
• Shares Outstanding (Diluted Average) came in at $11.4 million for Q1 2026 at Ascendis Pharma A, up from $4.4 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $11.4 million in Q1 2026 to a low of $1.7 million in Q1 2025.
• The 5-year median for Shares Outstanding (Diluted Average) is $4.5 million (2023), against an average of $5.2 million.
• Across the five-year window, Shares Outstanding (Diluted Average) plunged 44.57% in 2025 and soared 586.82% in 2026, its largest moves.
• Ascendis Pharma A's Shares Outstanding (Diluted Average) stood at $7.0 million in 2022, then increased by 0.23% to $7.0 million in 2023, then decreased by 0.59% to $7.0 million in 2024, then plunged by 37.28% to $4.4 million in 2025, then surged by 160.8% to $11.4 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $11.4 million (Q1 2026), $4.4 million (Q4 2025), and $3.8 million (Q3 2025), per Business Quant data.